Dechra Pharmaceuticals says Q1 performance in line
Dechra Pharmaceuticals said its first-quarter performance was in line with management's views and that all of its recent acquisitions were performing well.
Dechra Pharmaceuticals
3,866.00p
08:01 16/01/24
0.00%
0.00p
FTSE 250
19,824.16
16:59 26/04/24
n/a
n/a
FTSE 350
4,470.09
16:59 26/04/24
n/a
n/a
FTSE All-Share
4,423.59
17:14 26/04/24
n/a
n/a
Pharmaceuticals & Biotechnology
22,773.26
16:59 26/04/24
0.10%
22.78
The company also confirmed the retirement of chairman Michael Redmond after its AGM on Friday, with successor Tony Rice thereafter taking over.